Hypogonadal men with moderate-to-severe lower urinary tract symptoms have a more severe cardiometabolic risk profile and benefit more from testosterone therapy than men with mild lower urinary tract symptoms.

Farid SaadGheorghe DorosKarim Sultan HaiderAhmad Haider

Published in: Investigative and clinical urology (2018)

Correcting hypogonadism by TTh is highly effective and safe for improving LUTS in hypogonadal men. TTh may also improve cardiometabolic risk and major adverse cardiovascular events.

Keyphrases

lower urinary tract symptoms
benign prostatic hyperplasia
replacement therapy
cardiovascular events
middle aged
coronary artery disease
cardiovascular disease
early onset
smoking cessation
emergency department
type diabetes
stem cells
high intensity
drug induced